Abbott Laboratories (ABT) is a Healthcare stock trading at $88.58 (as of 2026-06-18), with a market capitalization of $151.52B and a trailing P/E of 24.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide across four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its product offerings include pharmaceutical therapies, diagnostic laboratory and molecular systems, point-of-care testing, and nutritional and medical device products for health care customers.